Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

797 ARTÍCULOS , VIENDO DEL 391 AL 405

Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective

Bobbins A, Davies M, Lynn E, Roy D, Yeomans A, Shakir SAW.

Br J Clin Pharmacol. 2025 May;91(5):1352-1360. doi: 10.1002/bcp.70021. Epub 2025 Mar 6.

Bioactive peptides as multipotent molecules bespoke and designed for Alzheimer's disease

Mesias A, Borges S, Pintado M, Baptista-Silva S.

Neuropeptides. 2025 Jun;111:102515. doi: 10.1016/j.npep.2025.102515. Epub 2025 Mar 4.

Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

Dahiya M, Yadav M, Goyal C, Kumar A.

Inflammopharmacology. 2025 Apr;33(4):1817-1831. doi: 10.1007/s10787-025-01704-2. Epub 2025 Mar 10.

Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review

Zaater MA, El Kerdawy AM, Mahmoud WR, Abou-Seri SM.

Int J Biol Macromol. 2025 May;307(Pt 3):142141. doi: 10.1016/j.ijbiomac.2025.142141. Epub 2025 Mar 14.

GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression

Rekha A, Afzal M, Babu MA, Menon SV, Nathiya D, Supriya S, Mishra SB, Gupta S, Goyal K, Rana M, Ali H, Imran M.

Mol Cell Neurosci. 2025 Jun;133:104005. doi: 10.1016/j.mcn.2025.104005. Epub 2025 Mar 20.

CaMKII mechanisms that promote pathological LTP impairments

Larsen ME, Rumian NL, Quillinan N, Bayer KU.

Curr Opin Neurobiol. 2025 Jun;92:102961. doi: 10.1016/j.conb.2024.102961. Epub 2025 Mar 31.

Ferroptosis and Alzheimer's: unveiling new avenues for the treatment and prevention

Sharma V, Sharma P, Singh TG.

Metab Brain Dis. 2025 Apr 1;40(4):167. doi: 10.1007/s11011-025-01587-w.

The endocannabinoid system offers a target for Alzheimer's disease treatment through inhibition of fatty acid amide hydrolase (FAAH)

de Ceballos ML.

FEBS J. 2025 Aug;292(16):4156-4159. doi: 10.1111/febs.70082. Epub 2025 Apr 2.

Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease

Mostafa M, Disouky A, Lazarov O.

Neurotherapeutics. 2025 Apr;22(3):e00580. doi: 10.1016/j.neurot.2025.e00580. Epub 2025 Apr 2.

Anticholinesterases Traits Inbuilt in Buxaceae Plant Extracts against Alzheimer's Disease

Patocka J, Sharma S, Navratilova Z, Singh N, Jelinkova R, Mehboob N, Oleksak P, Nepovimova E, Kuca K.

Curr Neuropharmacol. 2025;23(10):1137-1155. doi: 10.2174/1570159X23666250326091016.

Mechanisms Linking Obesity, Insulin Resistance, and Alzheimer's Disease: Effects of Polyphenols and Omega-3 Polyunsaturated Fatty Acids

Yavari M, Kalupahana NS, Harris BN, Ramalingam L, Zu Y, Kahathuduwa CN, Moustaid-Moussa N.

Nutrients. 2025 Mar 29;17(7):1203. doi: 10.3390/nu17071203.

An Insight into the Recent Advancement in Anti-Alzheimer's Potential of Indole Derivatives and their SAR Study

Mondal R, Paliwal D, Thakur A, Kaushik N.

Curr Top Med Chem. 2025;25(24):2848-2863. doi: 10.2174/0115680266358563250331175140.

Biofilm Biology to Brain Health: Harnessing Microbial Wisdom to Uncover Amyloid Dissociating Bifunctional Nano Chaperones for Alzheimer's Therapeutics

Randhawa S, Saini TC, Bathla M, Teji N, Acharya A.

ACS Chem Neurosci. 2025 May 7;16(9):1647-1661. doi: 10.1021/acschemneuro.4c00868. Epub 2025 Apr 18.

Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force

Angioni D, Middleton L, Bateman R, Aisen P, Boxer A, Sha S, Zhou J, Gerlach I, Raman R, Fillit H, Salloway S, Sperling R, Vellas B, Cummings J.

J Prev Alzheimers Dis. 2025 Jun;12(6):100163. doi: 10.1016/j.tjpad.2025.100163. Epub 2025 Apr 18.

Unraveling the Immune Puzzle: Role of Immunomodulation in Alzheimer's Disease

Ashvin, Dhapola R, Kumari S, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.

J Neuroimmune Pharmacol. 2025 Apr 29;20(1):47. doi: 10.1007/s11481-025-10210-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias